RPID Rapid Micro Biosystems Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: RPID

Price (delayed)

$0.89

Market cap

$37.82M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.22

Enterprise value

$20.6M

Highlights
RPID's gross margin has soared by 51% year-on-year and by 37% since the previous quarter
The gross profit is up by 36% year-on-year and by 31% since the previous quarter
Rapid Micro Biosystems's equity has decreased by 28% YoY and by 8% QoQ
RPID's quick ratio is down by 14% year-on-year and by 14% since the previous quarter
Sector: Healthcare
Industry: Diagnostics & Research

Key stats

What are the main financial stats of RPID
Market
Shares outstanding
42.5M
Market cap
$37.82M
Enterprise value
$20.6M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.32
Price to sales (P/S)
1.7
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.91
Earnings
Revenue
$22.52M
EBIT
-$56.65M
EBITDA
-$52.34M
Free cash flow
-$46.93M
Per share
EPS
-$1.22
Free cash flow per share
-$1.09
Book value per share
$2.78
Revenue per share
$0.52
TBVPS
$3.33
Balance sheet
Total assets
$143.45M
Total liabilities
$25.46M
Debt
$7.35M
Equity
$117.99M
Working capital
$101.43M
Liquidity
Debt to equity
0.06
Current ratio
6.34
Quick ratio
5.15
Net debt/EBITDA
0.33
Margins
EBITDA margin
-232.4%
Gross margin
-24.4%
Net margin
-233%
Operating margin
-251.2%
Efficiency
Return on assets
-33.4%
Return on equity
-39%
Return on invested capital
-46%
Return on capital employed
-45.5%
Return on sales
-251.5%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

RPID stock price

How has the Rapid Micro Biosystems stock price performed over time
Intraday
-9.18%
1 week
-6.32%
1 month
-9.64%
1 year
-0.84%
YTD
20.27%
QTD
-8.25%

Financial performance

How have Rapid Micro Biosystems's revenue and profit performed over time
Revenue
$22.52M
Gross profit
-$5.49M
Operating income
-$56.56M
Net income
-$52.47M
Gross margin
-24.4%
Net margin
-233%
RPID's gross margin has soared by 51% year-on-year and by 37% since the previous quarter
The gross profit is up by 36% year-on-year and by 31% since the previous quarter
Rapid Micro Biosystems's net margin has increased by 34% YoY and by 17% from the previous quarter
Rapid Micro Biosystems's operating margin has increased by 32% YoY and by 16% QoQ

Growth

What is Rapid Micro Biosystems's growth rate over time

Valuation

What is Rapid Micro Biosystems stock price valuation
P/E
N/A
P/B
0.32
P/S
1.7
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.91
Rapid Micro Biosystems's EPS has increased by 15% YoY and by 9% from the previous quarter
Rapid Micro Biosystems's equity has decreased by 28% YoY and by 8% QoQ
RPID's P/B is 7% above its last 4 quarters average of 0.3
RPID's revenue is up by 31% YoY and by 10% from the previous quarter
The P/S is 26% below the last 4 quarters average of 2.3

Efficiency

How efficient is Rapid Micro Biosystems business performance
Rapid Micro Biosystems's ROS has increased by 32% YoY and by 16% from the previous quarter
The ROE has contracted by 20% YoY
RPID's ROIC is down by 17% year-on-year
Rapid Micro Biosystems's ROA has decreased by 15% YoY but it has increased by 2.3% from the previous quarter

Dividends

What is RPID's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for RPID.

Financial health

How did Rapid Micro Biosystems financials performed over time
Rapid Micro Biosystems's total assets has decreased by 25% YoY and by 4.5% from the previous quarter
The current ratio has contracted by 14% from the previous quarter and by 13% YoY
Rapid Micro Biosystems's debt is 94% less than its equity
Rapid Micro Biosystems's equity has decreased by 28% YoY and by 8% QoQ
The debt to equity has increased by 20% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.